An Intracavitary Electrocardiographic System for Real-time Positioning Peripherally Inserted Central Catheter Tip (PROJECT_EGG)

A Randomized Open-labeled Multicenter Study to Assess a New Intracavitary Electrocardiographic Guiding Method for Real-time Positioning the Tip of Three-way Valve Type Peripherally Inserted Central Catheters (PROJECT_EGG)

The purpose of this study is to compare a new intracavitary ECG guiding method for real-time positioning the tip of three-way valve type peripherally inserted central catheters versus conventional surface prediction length method in terms of single-time target rate.

Study Overview

• Status: Completed
• Conditions: Peripherally Inserted Central Catheter; Intracavitary Electrocardiogram Guiding
• Intervention / Treatment: Device: ECG; Procedure: Surface prediction length method

Detailed Description

The use of peripherally inserted central catheters (PICCs) has increased significantly for cancer patients receiving chemotherapy. For these patients, PICCs afford many advantages with regards to complications and treatment convenience.

Current practice utilizes the estimated length of the catheter from puncture site to the junction of superior vena cava / right atrium (SVC-RA) for guiding tip placement. Next the catheter tip placement was confirmed by radiographic imaging prior to use of the line for administration of chemotherapy medications. In this case, the catheter is often mal-positioned and requires adjustment and repeat radiographic imaging in order to ensure proper placement, ideally at the SVC-RA junction. These potentially additional procedures are time-consuming and also expose patients, nurses and physicians to radiations.

Intracavitary electrocardiogram with an electrode placed inside the catheter during insertion has shown identifiable changes in P-wave, which are sufficient to guide PICC tip placement. Moreover, less procedural time and radiation are expected.

This study aims to demonstrate if this intracavitary electrocardiogram guided method is superior to conventional surface prediction length method in terms of single-time target rate of correct tip placement. In addition, we would like to investigate symptomatic thrombosis incidence and its risk factors after three-valve PICC implanted among patients with malignant tumors; to clarify procedure time used and cost of the new intracavitary ECG guiding method and to explore the maximal P-wave amplitude of intracavity ECG real-time positioning technology and its predictive factors.

• Study Type: Interventional
• Enrollment (Actual): 1007
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Jiangsu
    • Nanjing, Jiangsu, China
      • Jiangsu Cancer Hospital
    • Nanjing, Jiangsu, China
      • Nanjing General Hospital of Nanjing Military Command
    • Nanjing, Jiangsu, China
      • Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
    • Nanjing, Jiangsu, China
      • Nanjing Hospital Affiliated to Nanjing Medical University
    • Nanjing, Jiangsu, China
      • The 2nd Affliated Hospital of Nanjing Medical University
    • Suzhou, Jiangsu, China
      • the First Affiliated Hospital of Soochow University
    • Suzhou, Jiangsu, China
      • The Second Affiliated Hospital of Soochow University
    • Zhenjiang, Jiangsu, China
      • People's Hospital Affiliated to Jiangsu University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 76 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Patients with malignant tumors who will require periodical infusion of chemotherapy drugs using three-valve PICC;
2. Aged >18 to < 80 years old;
3. Baseline ECG records prior to PICC catheter showed normal P wave;

4. Agreed to participate in this study, and signed PICC informed consent.

   Exclusion Criteria:

5. Patients with heart diseases, such as valvular heart disease, atrial fibrillation, supraventricular tachycardia, pulmonary heart disease or having a pacemaker and post cardiac surgery which may affect P waves.
6. Patients unable to lie in the prostrate or semi-supine position.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: ECG-guided PICC Tip Placement; New intracavitary ECG guiding method	Device: ECG; The ECG-guided PICC tip detection method will be used to identify catheter tip location during the procedural placement of the catheter. This method involves an ECG monitor which will be connected to the guidewire used for catheter placement. The changes in the ECG p-wave will guide correct PICC placement. An X-ray radiograph will be conducted to confirm the tip location after PICC placement.
Active Comparator: Conventional; Surface prediction length method	Procedure: Surface prediction length method; The method will estimate the length of the catheter from puncture site to the junction of superior vena cava / right atrium (SVC-RA) . Tip location is placed according to the estimated length but later on will be determinated by chest X-ray performed after the placement procedure. If the tip location is not at an ideal place, additional procedures and X-ray radiograph would be required in order to ensure proper tip location.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Single-time target rate	Less than 24 hours

Collaborators and Investigators

• Sponsor: Yuan Ling
• Investigators: Principal Investigator: Ling Yuan, Master, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Publications and helpful links

General Publications

• Yuan L, Li R, Meng A, Feng Y, Wu X, Yang Y, Chen P, Qiu Z, Qi J, Chen C, Wei J, Qin M, Kong W, Chen X, Xu W. Superior success rate of intracavitary electrocardiogram guidance for peripherally inserted central catheter placement in patients with cancer: A randomized open-label controlled multicenter study. PLoS One. 2017 Mar 9;12(3):e0171630. doi: 10.1371/journal.pone.0171630. eCollection 2017.

Study record dates

Study Major Dates

• Study Start: March 1, 2015
• Primary Completion (Actual): June 1, 2015
• Study Completion (Actual): October 1, 2015

Study Registration Dates

• First Submitted: April 1, 2015
• First Submitted That Met QC Criteria: April 6, 2015
• First Posted (Estimate): April 7, 2015

Study Record Updates

• Last Update Posted (Actual): April 14, 2022
• Last Update Submitted That Met QC Criteria: April 7, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 2015-001